ArticleJournal of surgical case reports2025
Solitary fibrous tumor of the nasal septum: a case report and literature review.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary fibrous tumors (SFT) are rare spindle cell neoplasms of mesenchymal origin, typically occurring in the pleura, with extra-pleural manifestations being uncommon. SFTs of the nasal cavity are particularly rare, with limited cases documented in the literature. This report presents the case of a 62-year-old female with a solitary fibrous tumor arising from the nasal septum. The patient presented with a unilateral nasal mass, obstruction, and nasal discharge, which did not improve with antibiotics. The tumor was successfully excised via an endonasal endoscopic approach, and histopathological analysis confirmed the diagnosis of an SFT with positive CD34 and CD99 markers. The patient remained symptom-free with no recurrence over 2 years of follow-up. This case highlights the importance of considering SFTs in the differential diagnosis of nasal masses and underscores the effectiveness of endonasal endoscopic resection as a minimally invasive treatment approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.